Ann Silk, MD
Dana-Farber Cancer Institute
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Joe Elassal, MD, MBA
Ankyra Therapeutics
Shared therapeutic areas:
Worked with same sponsors:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Peter Wolf, MD
Medical University of Graz
Shared therapeutic areas:
Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Jinming Yu, PhD
Shandong Cancer Hospital and Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
All 2 trials loaded